Drugs / hUC-MSC-sEV-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07404709 | Feb 2026 → Dec 2027 expected | sudden hearing loss disorder | The Affiliated Hospital of Qingdao University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hUC-MSC-sEV-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07404709 ↗ |
| Modality | Other / unclassified | “small extracellular vesicles derived from mesenchymal stem cells” NCT07404709 ↗ |
| Route | Other | “The intratympanic injection of small extracellular vesicles was given” NCT07404709 ↗ |